Lysergide d-tartrate for attention deficit disorder with hyperactivity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Dec 2021: Trial started, NCT05200936
  2. 21 Jan 2022: Trial registered, NCT05200936

The trials

NCT05200936: Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial

State
Completed
Phase
Phase 2
People
53 taking part
Started
17 Dec 2021
Primary completion
6 Nov 2023
Arms
Arm 2- MM120
Results
Posted on the registry
  1. 17 Dec 2021: Trial started
  2. 21 Jan 2022: Trial registered
  3. 4 Dec 2023: Trial completed
  4. 13 Apr 2025: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.